Related Experiment Video
Updated: Oct 28, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Percutaneous coronary intervention of chronic total occlusion - to whom, when and why
Insights
Chronic total occlusion (CTO) involves a complete blockage in a coronary vessel for over three months. Successful percutaneous intervention for CTO improves exercise capacity and quality of life.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Biology
Background:
- Chronic total occlusion (CTO) is defined as a complete cessation of blood flow in a coronary artery for at least three months.
- Distal arterial segments are typically supplied by collateral circulation, which may preserve myocardial viability but often fails to prevent exercise-induced ischemia.
- CTO is associated with poorer outcomes in patients with acute coronary syndromes affecting non-infarct-related arteries.
Purpose of the Study:
- To evaluate the impact of percutaneous intervention for CTO on ischemia reduction, exercise capacity, and quality of life.
- To assess the effect of successful CTO recanalization on left ventricular systolic function.
- To understand the short- and long-term outcomes of patients with CTO, particularly in the context of acute coronary syndromes.
Main Methods:
- Review of percutaneous coronary intervention (PCI) techniques for CTO.
- Analysis of procedural success rates and complication rates in contemporary CTO interventions.
- Evaluation of clinical outcomes, including exercise capacity, quality of life, and left ventricular function, following CTO recanalization.
Main Results:
- Successful recanalization of CTO leads to improved left ventricular systolic function.
- Percutaneous intervention for CTO aims to reduce ischemia and enhance exercise capacity and quality of life.
- Technological advancements and experienced operators have significantly improved success rates and maintained acceptable complication rates in CTO interventions.
Conclusions:
- Percutaneous intervention for CTO offers significant benefits in improving patient outcomes and quality of life.
- CTO interventions have evolved with improved success rates and manageable complications.
- Addressing CTO is crucial for improving cardiac function and patient prognosis, especially in acute coronary syndromes.
Abstract:
Chronic total occlusion is characterised by total discontinuation of a blood flow in coronary vessel present for at least three months. Typical finding involves filling of the distal arterial segments by collateral flow. Well developed collaterals usually provide sufficient supply to preserve myocardial viability, but frequently are not capable of preventing excercise ischemia in the occluded territory. Percutaneous intervention of a CTO is focused on ischemia reduction, improvement of excercise capacity and quality of life. A succesful recanalization of a CTO leads to an improvement of left ventricular systolic function. Patients presenting with acute coronary syndromes and a coincident CTO in non-infarct related artery show worse short and long-term outcomes as compared to patients without a CTO. Technolocigal and procedural evolvement over past decades with implementation of novel techniques used by experienced operators lead to a substantial succes rate imprevement with acceptable complications rate in contemporary CTO interventions.
More Related Videos
12:00Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations